1370
Y. Zeng et al. / Carbohydrate Research 337 (2002) 1367–1371
(2:1 petroleum ether–EtOAc) to give 13 (0.6 g, 70% for
two steps) as a white foam: [h]D −19.6° (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3): l 8.69 (s, 1 H, NH),
8.15–7.21 (m, 50 H, 10 BzH), 6.59 (d, 1 H, J1,2 2.3 Hz,
H-1), 6.24 (dd, 1 H, J3,4=J4,5 10.1 Hz, H-4%%%), 6.05 (dd,
1 H, J3,4=J4,5 10.3 Hz, H-4%), 5.97 (dd, 1 H, J3,4=J4,5
10.1 Hz, H-4%%), 5.81 (dd, 1 H, J2,3 3.2, J3,4 10.1 Hz,
H-3%%%), 5.78 (dd, 1 H, J2,3 3.1, J3,4 10.3 Hz, H-3%), 5.73
(dd, 1 H, J2,3 3.2, J3,4 10.1 Hz, H-3%%), 5.47–5.39 (m, 3
H, H-1%%%, H-1%%, H-3), 5.30 (d, 1 H, J1,2 1.6 Hz, H-1%),
5.23 (dd, 1 H, J3,4=J4,5 12.0 Hz, H-4), 4.71–4.34 (m,
13 H, H-2%%%, H-2%%, H-2%, H-2, H-5%%%, 2 H-6%%%, 2 H-6%%, 2
H-6%, 2 H-6), 3.96 (m, 3 H, H-5%%, H-5%, H-5), 2.22 (s, 3
H, MeCO), 2.04 (s, 3 H, MeCO), 2.02 (s, 3 H, MeCO).
Anal. Calcd for C102H88Cl3NO34: C, 61.93; H, 4.48.
Found: C, 61.78; H, 4.43.
Allyl
(13)-2,4,6-tri-O-acethyl-h-
3,4,6-tri-O-benzoyl-h- -mannopyranosyl-(12)-3,4,6-
tri-O-benzoyl-h- -mannopyranosyl-(16)-2,3,4-tri-O-
benzoyl-h- -mannopyranosyl-(12)-3,4,6-tri-O-ben-
zoyl-h- -mannopyranosyl-(12)-3,4,6-tri-O-benzoyl-
h- -mannopyranoside (17).—Under the same condi-
2,3,4,6-tetra-O-benzoyl-h-
D-mannopyranosyl-
D
-mannopyranosyl-(12)-
D
D
D
D
D
tions as described for the synthesis of 3 by coupling of
1 with 2, heptasaccharide 17 (94 mg, 51%) was obtained
from coupling of 13 (150 mg, 0.076 mmol) with 16 (100
mg, 0.067 mmol): [h]D −19.6° (c 1.0, CHCl3); 1H
NMR (400 MHz, CDCl3): l 8.19–7.20 (m, 95 H, 9
BzH), 6.31–6.18 (m, 2 H, 2 H-4), 6.08–5.63 (m, 11 H,
H-2, 4 H-3, 5 H-4, CHꢀCH2), 5.51–5.15 (m, 10 H, 4
H-1, H-2, 3 H-3, 2 CHꢀCH2), 4.81–4.33 (m, 22 H, 3
H-1, 3 H-2, 4 H-5, 12 H-6), 4.30–4.08 (m, 5 H, 2 H-5,
2 H-6, CH2ꢁCHꢀCH2), 4.06–3.68 (m, 4 H, 2 H-2, H-5,
CH2ꢁCHꢀCH2), 2.19 (s, 3 H, MeCO), 1.94 (s, 3 H,
MeCO), 1.85 (s, 3 H, MeCO). 13C NMR (100 MHz,
CDCl3): l 170.1, 169.8, 169.6 (3 C, 3 MeCO), 166.2,
165.9, 165.8, 165.7, 165.6, 165.5, 165.3, 165.2, 165.1,
165.0, 164.9 (19 C, PhCO), 133.7–132.2, 130.2–129.2,
129.1–127.9 (PhCO, ꢁCH2ꢁCHꢀCH2), 118.0 (1 C,
ꢁCH2ꢁCHꢀCH2), 100.6, 99.8, 99.8, 99.7, 99.0, 98.3,
98.0 (7 C-1), 77.3 (C-3%%%%%), 73.4, 72.2, 71.3, 70.8, 70.6,
70.3, 70.1, 70.0, 69.7, 69.6, 69.4, 69.2, 68.7, 68.5, 67.2,
66.3, 65.9, 65.8, 63.6, 63.5, 62.9, 62.8, 62.2, 62.0 (C-2–
C-6, ꢁCH2ꢁCHꢀCH2), 21.4, 20.7, 20.5 (3 MeCO). Anal.
Calcd for C184H158O58: C, 67.03; H, 4.83. Found: C,
67.10; H, 4.82.
Allyl 2,3,4-tri-O-benzoyl-h-
2)-3,4,6-tri-O-benzoyl-h- -mannopyranosyl-(12)-
3,4,6-tri-O-benzoyl-h- -mannopyranoside (16).—To a
D
-mannopyranosyl-(1
D
D
cooled solution (0 °C) of 10 (1.01 g, 1 mmol) and 14
(0.81g, 1.2 mmol) in anhyd CH2Cl2 (50 mL) was added
TMSOTf (30 mL, 0.12 mmol). The mixture was stirred
at 0 °C for 2 h and then quenched with Et3N (2 drops).
The solvent was evaporated to give a residue, which
was purified by silica gel column chromatography (2:1
petroleum ether–EtOAc) to give trisaccharide 15 as a
foamy solid (1.24 g, 82%). Compound 15 was dissolved
in anhyd MeOH (200 mL) and CH2Cl2 (100 mL), and
to the mixture was added AcCl (1.2 mL). The flask was
stoppered, and the solution was stirred at rt until TLC
(1:1 petroleum ether–EtOAc) showed that the starting
material disappeared (2 h). The solution was neutral-
ized with Et3N, then concentrated to dryness. The
residue was passed through a short silica gel column
(1:2 petroleum ether–EtOAc) to give 16 (810 mg, 67%
for two steps) as a white solid: [h]D −71.5° (c 1.0,
Allyl h-
osyl-(12)-h-
pyranosyl - (16) - h -
mannopyranosyl-(12)-h-
D
-mannopyranosyl-(13)-h-
-mannopyranosyl-(12)-h-
- mannopyranosyl - (12) - h -
-mannopyranoside (18).—
D
-mannopyran-
D
D
-manno-
D
D-
D
Compound 17 (75 mg, 0.0275 mmol) was dissolved in
satd NH3–MeOH (10 mL). After 2 weeks at rt, the
reaction solution was concentrated, and the residue was
purified on a BioGel P2 column with MeOH–water as
the eluent to afford 18 (24 mg, 80%) as a pulverous
1
CHCl3); H NMR (400 MHz, CDCl3): l 8.14–7.24 (m,
45 H, 9 BzH), 6.04–5.86 (m, 5 H, H-3%%, H-4, H-4%,
H-4%%, CHꢀCH2), 5.71–5.65 (m, 3 H, H-3, H-3%,H-2%%),
5.39 (d, 1 H, J1,2 1.5 Hz, H-1%%), 5.27 (dd, 1 H, J 1.4, J
17.2 Hz, CHꢀCH2), 5.18 (dd, 1 H, J 1.4, J 10.3 Hz,
CHꢀCH2), 5.14 (d, 1 H, J1,2 1.9 Hz, H-1%), 4.73 (d, 1 H,
J1,2 1.0 Hz, H-1), 4.63–4.50 (m, 6 H, H-5%%, 2 H-6%%, 2
H-6%, H-6),. 4.41–4.36 (m, 2 H, H-5%, H-6), 4.18 (dd, 1
H, J 6.0, J 12.7 Hz, CH2ꢁCHꢀCH2), 4.11 (ddd, 1 H, J4,5
11.3, J5,6a 8.8, J5,6b 4.4 Hz, H-5), 3.96 (dd, 1 H, J 6.0, J
12.7 Hz, CH2ꢁCHꢀCH2), 3.52 (m, 2 H, H-2%, H-2). 13C
NMR (100 MHz, DCCl3): l 166.2, 166.2, 166.0, 166.0,
165.4, 165.2, 165.1, 164.9, 164.7 (9 C, 9 PhCO), 133.5–
1
crystalloid: [h]D +52.6° (c 1.0, water); H NMR (400
MHz, D2O): l 5.87 (m, 1 H, CHꢀCH2), 5.25 (dd, 1 H,
J 1.6, J 17.2 Hz, CHꢀCH2), 5.20, 5.18, 5.10, 5.05, 5.04
(5 H, H-1), 5.01 (dd, 1 H, J 1.6, J 10.8 Hz, CHꢀCH2),
4.94, 4.94 (2 H, H-1), 4.18–3.40 (m, 44 H,
CH2ꢁCHꢀCH2, H-2–H-6). 13C NMR (100 MHz, D2O):
l
132.7 (1 C, ꢁCH2ꢁCHꢀCH2), 117.9 (1 C,
ꢁCH2ꢁCHꢀCH2), 101.7, 101.7, 101.6, 100.3, 100.0, 97.7,
96.9 (7 C-1, JC-1,H-1 172.0–173.5 Hz), 78.2, 78.1, 78.0,
77.8, 77.4, 75.4, 75.2, 75.0, 73.6, 72.9, 72.8, 72.8, 72.4,
72.3, 72.2, 71.5, 71.1, 70.2, 70.0, 70.0, 69.8, 69.7, 69.5,
69.4, 69.1, 67.6, 66.5, 66.4, 66.3, 65.8, 65.6, 61.9, 60.5,
60.4, 60.2, 60.2 (C-2–C-6, ꢁCH2ꢁCHꢀCH2). Anal.
Calcd for C45H76O36: C, 45.30; H, 6.42. Found: C,
45.17; H, 6.47.
132.6,
130.0–128.2
(PhCO),
118.0
(1
C,
ꢁCH2ꢁCHꢀCH2), 100.4, 99.7, 98.0 (3 C, 3 C-1), 71.9,
71.9, 70.3, 70.0, 69.6, 69.3, 68.7, 68.7, 68.6, 67.3, 67.0,
66.7, 63.5, 63.5, 61.6, 61.4 (C-2–C-6, ꢁCH2ꢁCHꢀCH2).
Anal. Calcd for C84H72O25: C, 68.10; H, 4.90. Found:
C, 67.90; H, 4.87.